LIFEVANTAGE CORP Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
LIFEVANTAGE CORP (LFVN) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-08-23.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2022-08-23
- LIFEVANTAGE CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LIFEVANTAGE CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was $7.00K, a 133.33% increase from fiscal 2020.
- LIFEVANTAGE CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was $3.00K.
- LIFEVANTAGE CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-08-23 |
| 2021-06-30 | $7.00K 10-K · filed 2022-08-23 |
| 2020-06-30 | $3.00K 10-K · filed 2022-08-23 |
| 2019-06-30 | $0.00 10-K · filed 2021-08-19 |
| 2018-06-30 | -$6.00K 10-K · filed 2020-08-18 |
| 2017-06-30 | -$12.00K 10-K · filed 2019-08-14 |
| 2016-06-30 | -$1.19M 10-K · filed 2018-08-15 |
| 2015-06-30 | $0.00 10-K · filed 2017-09-07 |
| 2014-06-30 | $0.00 10-K · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |